AtriCure (ATRC) Tops Q1 EPS by 8c ; Offers Guidance
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $48.35 -0.39%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
RIBT, INLB, FTXP, More
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
RIBT, INLB, FTXP, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q1 EPS of ($0.14), $0.08 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $123.6 million versus the consensus estimate of $123.08 million.
GUIDANCE:
AtriCure sees FY2025 EPS of ($0.50)-($0.55), versus the consensus of ($0.58). AtriCure sees FY2025 revenue of $517-527 million, versus the consensus of $522.8 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
- Hyper Bit Technologies closes $1.49M private placement
- Altrova Health Reports Third Quarter Fiscal 2026 Financial Results
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
